您现在的位置是:星锐新声 > 百科
Weight regain happens 4x faster after stopping GLP
星锐新声2026-02-01 04:32:17【百科】5人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(551)
上一篇: 英雄联盟海克斯大乱斗物转法怎么玩
相关文章
- Hộ kinh doanh vượt 500 triệu đồng vẫn phải nộp thuế VAT từ đồng đầu tiên
- 随着DS和3DS价格飙升 任天堂粉丝后悔没有早点入手
- 小肥羊羴鱻锅新鲜上市
- 受天气影响 1月21日铁路宁波站部分列车停运
- กัมพูชาดัดแปลงหัวกระสุนปืนใหญ่เป็นทุ่นระเบิดสังหารบุคคลที่บ้านสามหลัง ตอกย้ำละเมิด กม.มนุษยธรรมฯ
- 崩坏星穹铁道神秘人交给你的线索怎么完成 神秘人交给你的线索在哪
- 第八届吴清源杯本赛在福州开赛 陆敏全等首轮胜出
- Accused Charlie Kirk shooter challenges prosecutor conflict
- Fami通周销榜:《马里奥赛车:世界》三连冠 累计销量近250万
- 创业板指跌逾1% 沪深京三市下跌个股超2600只
站长推荐
友情链接
- 间装修样板房设计方法 样板房设计要点
- 酒店管理论文范文集锦
- 杨梅品种大全及什么品种最好吃
- 深化校企合作 共育环保英才——马鞍山学院校长姚佐文一行到访华骐环保交流
- 劳力士代言人德国名将丹尼尔·杜瑟称雄法国拉博尔马术五星级1.5米争时赛
- Báo Indonesia: U22 ẵm HCV SEA Games và quyền lực bóng đá Việt Nam
- 《中国改革报》:全力保障复工复产
- dnf手游65版本升级攻略 65级版本怎么升级最快
- 数字人民币试点地区累计交易金额达14.2万亿元
- 海沧“本土十佳名小吃、荟萃十佳名小吃”出炉
- 低利率环境下,钱该放哪里
- 周六足彩伤停:巴萨中场伤情严重 热刺失三大主力
- 《剑星2》新概念图汇总 非常棒让粉丝激动不已
- 晋城市“太行一号”旅游公路正式投入运营
- 海报丨高考成绩出炉,这些骗局得防
- ไขปริศนาเห็ดลึกลับที่ทำให้คนกินเห็นภาพหลอนเป็นมนุษย์ตัวเล็กจิ๋ว
- 长生天机降世主线任务十一通关攻略
- 日本记者:中国队有令人意想不到的技术 未来还会继续进步
- 新华社:我国企业需要更多“达摩院”和“好人品”
- [新浪彩票]足彩25175期盈亏指数:尤文拜仁取胜






